These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11128246)

  • 1. Increased seizures after discontinuing carbamazepine: results from the gabapentin monotherapy trial.
    DeToledo JC; Ramsay RE; Lowe MR; Greiner M; Garofalo EA
    Ther Drug Monit; 2000 Dec; 22(6):753-6. PubMed ID: 11128246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monotherapy trials with gabapentin for partial epilepsy.
    Beydoun A
    Epilepsia; 1999; 40 Suppl 6():S13-6; discussion S73-4. PubMed ID: 10530677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxcarbazepine in focal epilepsy and hepatic porphyria: a case report.
    Gaida-Hommernick B; Rieck K; Runge U
    Epilepsia; 2001 Jun; 42(6):793-5. PubMed ID: 11422339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin as adjunctive therapy for partial seizures.
    Bruni J
    Epilepsia; 1999; 40 Suppl 6():S27-8; discussion S73-4. PubMed ID: 10530680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin.
    Morris GL
    Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin: discussion.
    Fromm GH
    Epilepsia; 1994; 35 Suppl 5():S77-80. PubMed ID: 8039476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term treatment with gabapentin for partial epilepsy.
    Ojemann LM; Wilensky AJ; Temkin NR; Chmelir T; Ricker BA; Wallace J
    Epilepsy Res; 1992 Nov; 13(2):159-65. PubMed ID: 1464301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Trials with gabapentin monotherapy in patients with complex partial or secondary generalized seizures].
    Pierce MW; Shokry A
    Praxis (Bern 1994); 1997 Sep; 86(37):1430-1. PubMed ID: 9381042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased seizure frequency associated with felbamate withdrawal in adults.
    Welty TE; Privitera M; Shukla R
    Arch Neurol; 1998 May; 55(5):641-5. PubMed ID: 9605720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gabapentin as adjuvant therapy in the treatment of refractory partial epilepsy].
    Tomović M; Ilić T; Mihajlović M; Jovicić A
    Vojnosanit Pregl; 1999; 56(2):151-6. PubMed ID: 10437420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers.
    Salinsky MC; Binder LM; Oken BS; Storzbach D; Aron CR; Dodrill CB
    Epilepsia; 2002 May; 43(5):482-90. PubMed ID: 12027908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome evaluation of gabapentin as add-on therapy for partial seizures. "NEON" Study Investigators Group. Neurontin Evaluation of Outcomes in Neurological Practice.
    Bruni J
    Can J Neurol Sci; 1998 May; 25(2):134-40. PubMed ID: 9604135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monotherapy using gabapentin in epilepsy].
    Sancho-Rieger J; López-Trigo J
    Rev Neurol; 2002 Feb 1-15; 34(3):290-2. PubMed ID: 12022083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of interaction of gabapentin with carbamazepine or valproate.
    Radulovic LL; Wilder BJ; Leppik IE; Bockbrader HN; Chang T; Posvar EL; Sedman AJ; Uthman BM; Erdman GR
    Epilepsia; 1994; 35(1):155-61. PubMed ID: 8112239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
    Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.